GPT-5 for Scientific Discovery

Welcome Sean. — Thanks Olivia. It's so good to be here. — Let's start with Amjen. What is the company mission? What do you guys build? — Amgen fights some of the world's toughest diseases by bringing together the best of biology and technology and that journey from a molecule to a medicine is exquisitly complex. How does TPT5 score in terms of reliability, — scientific accuracy and decision quality have to be held at the highest standards? And we've been able to really thoughtfully embed GPT5 in some really important workflows around the company. — Within OpenAI, we felt something different about GT5. What did you guys think about it? How does it feel like to use the model? — GPT5 does a better job in situations that are ambiguous, where the context matters. GPT5 performs better quantitatively on objective measures of quality. We think this might be one of those big breakthrough moments. — What would an accelerating rate of progress for models would mean for you all and for people? — We believe that advancements in artificial intelligence have the potential to fundamentally change the field of biotechnology. Breakthroughs like GPT5 help us to accelerate our mission of serving patients.